Ferring Announces New Collaboration for Development of Olamkicept

Strategic collaboration to further develop olamkicept highlights Ferring’s continued commitment to innovation in gastroenterology and inflammatory bowel disease. Olamkicept is the first and only clinical stage selective interleukin-6 (IL-6) inhibitor that works through the trans-signaling mechanism. IL-6 is associated with a number of inflammatory conditions, such as inflammatory bowel disease (IBD). SAINT-PREX, Switzerland–(BUSINESS WIRE)–#Ferring–Ferring Pharmaceuticals … [Read more…]

Better Therapeutics to Participate in Cowen’s Unlocking the Value of Digital Prescription Therapeutics Webinar on June 16, 2022

SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that it will participate in a webinar on Unlocking the Value of Digital Prescription Therapeutics hosted by Cowen to discuss the recently released promising pivotal clinical … [Read more…]

Athersys Postpones Annual Meeting of Stockholders

Annual Meeting of Stockholders rescheduled to Thursday, July 28, 2022, 8:30 a.m. ET CLEVELAND–(BUSINESS WIRE)–$ATHX–Athersys, Inc. (Nasdaq: ATHX) today announced the postponement of its Annual Meeting of Stockholders, initially scheduled for Wednesday, June 15, 2022, at 8:30 a.m. ET. The Annual Meeting is now scheduled for Thursday, July 28, 2022, at 8:30 a.m. ET. The … [Read more…]

Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy

– Cemdisiran Treatment Resulted in a 37 Percent Mean Reduction in 24-Hour Urine Protein to Creatinine Ratio, Relative to Placebo – a Key Prognostic Marker of Progression to End-Stage Kidney Disease in Patients with IgA Nephropathy – – Acceptable Safety Profile, Supporting Continued Clinical Development – – Full Results to Be Presented at Future Medical … [Read more…]

Spectrum Chemical Enters into New Distribution Arrangement with ANGUS Chemical Company to Provide Select TRIS Buffers and Derivatives for Life Sciences and Biopharmaceuticals Markets in United States and Canada

GARDENA, Calif.–(BUSINESS WIRE)–#SpectrumbioCERTIFIED—Spectrum Chemical Mfg. Corp. (“Spectrum Chemical”), a leading global provider of fine chemicals, laboratory equipment and supplies, has entered into a new distribution arrangement with ANGUS Chemical Company (“ANGUS”) that expands Spectrum Chemical’s product offerings for research and development and production scale-up at commercial and academic organizations serving the biopharmaceutical and life sciences … [Read more…]

Clinical Trials Sector Scorecard 2022: Artificial Intelligence, Virtual Care and Blockchain Saw Activity in Q1 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trials Sector Scorecard – Q1 2022 Update – Thematic Research” report has been added to ResearchAndMarkets.com’s offering. Many companies included in the Clinical Trials scorecard have announced partnerships in the artificial intelligence (AI) space since December 2021. Pfizer announced partnerships in drug discovery and disease severity scoring, while Thermo Fisher Scientific announced … [Read more…]

South Africa Over-the-Counter (OTC) Healthcare Market Forecast to 2026: OTC Healthcare Sector Forecast to Register CAGR of 36% During 2021-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “South Africa Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The report on the OTC healthcare sector in South Africa provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market … [Read more…]

Ipsen Receives Positive Opinion in Europe for Dysport® in the Management of Urinary Incontinence in Adults With Neurogenic Detrusor Overactivity Due to Multiple Sclerosis or Spinal Cord Injury

Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently published in European Urology1 CONTENT showed that Dysport® decreased incontinence episodes, detrusor pressure and increased bladder capacity versus placebo, and improved quality of life1 PARIS–(BUSINESS WIRE)–Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: … [Read more…]

The Worldwide Human Growth Hormone Drugs Industry is Projected to Reach $4 Billion by 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Human Growth Hormone Drugs – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Human Growth Hormone Drugs estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2026, growing at a CAGR of 3.5% over the … [Read more…]

Insights on the Pharmacy Repackaging Systems Global Market to 2027 – Serialization Drives New Design Developments in Pharma Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmacy Repackaging Systems – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Pharmacy Repackaging Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 7.5% over the analysis period … [Read more…]